To achieve a thorough understanding of marketing and commercial strategies within the Rare Diseases Franchise. This unique program will be in support of Global commercial and brand strategy development during the first year, followed by tactical implementation and execution of these strategies in the United States during the second year. The Fellow will work in several key functional areas within the commercial organization. Upon completion of this program, Fellows will gain an understanding of competitive dynamics and customer needs. In addition, they will be well versed in product positioning and resonant marketing content generation. The experience will enable Fellows to embark on a career within the pharmaceutical industry in product management, commercialization, and market development.
Assist the cross-functional core team in the development of Global and US brand strategy, and support its implementation.
Collaborate on the development and refinement of product value messaging and disease-awareness materials to support strategic priorities globally and regionally.
Increase brand and disease state awareness through coordinated marketing opportunities at conferences.
Lead and execute orphan disease awareness and product marketing campaigns targeted at HCPs and patients.
Manage agency partners to produce strategic materials on schedule and within budget.
Identify data gaps and develop appropriate solutions via the coordination of market research activities.
Compile and disseminate competitive intelligence insights across the global, regional, and country brand teams.
Provide commercial assessments regarding business development opportunities that may complement the Rare Diseases portfolio.
Gain insight into the integral and strategic roles of various functions within the Rare Diseases Business Unit throughout the lifecycle of a product.
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS Fluid Review application portal. Visit https://mcphs.fluidreview.com/
Please DO NOT request an interview within PPS.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal due by December 2, 2019:
Letter of intent
Unofficial college transcript
Contact information of three references for their recommendations.
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
After ASHP Midyear Clinical Meeting
The three letters of recommendation must be submitted by the three provided contacts no later than December 16th
Top candidates will be invited for onsite interviews at the sponsoring company’s location. Final candidates will be required to go through additional screening / onboarding as required by MCPHS University.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Additional Salary Information: Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
About MCPHS University/Sanofi Genzyme
Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.